A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

BACKGROUND: The raising prevalence of type-2 diabetes mellitus and obesity has been recognized as a major problem for public health, affecting both developed and developing countries. Impaired fasting plasma glucose has been previously associated with endothelial dysfunction, higher levels of inflam...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: López-Jaramillo, Patricio, Pradilla, Lina P, Lahera, Vicente, Sieger, Federico A Silva, Rueda-Clausen, Christian F, Márquez, Gustavo A
פורמט: Artigo
שפה:Inglês
יצא לאור: BioMed Central 2006
נושאים:
Study Protocol
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC1594582/
https://ncbi.nlm.nih.gov/pubmed/16959033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-7-28
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים